PEP
41
-4
PFG
67
2
ECL
52
-3
DTE
38
-4
EMR
70
2
KO
44
-2
APD
52
-2
DE
45
-3
HIG
50
-2
PGR
49
-3
MET
60
2
CF
42
-6
ADT
48
3
MHK
46
-7
ORCL
37
3
WFC
69
-2
AA
72
2
BBY
50
9
VNO
49
8
HBAN
74
-2
PEP
41
-4
PFG
67
2
ECL
52
-3
DTE
38
-4
EMR
70
2
KO
44
-2
APD
52
-2
DE
45
-3
HIG
50
-2
PGR
49
-3
MET
60
2
CF
42
-6
ADT
48
3
MHK
46
-7
ORCL
37
3
WFC
69
-2
AA
72
2
BBY
50
9
VNO
49
8
HBAN
74
-2
Financhill
Back

Clene, Inc. 10K Form

Sell
15

CLNN
Clene, Inc.

Last Price:
$5.71
Seasonality Move:
-1.03%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2021-03-29 10K CLNN/Clene, Inc. Annual
2020-11-03 10Q CLNN/Clene, Inc. Quarterly
2020-09-04 10K CLNN/Clene, Inc. Annual
2020-08-03 10Q CLNN/Clene, Inc. Quarterly
2020-05-14 10Q CLNN/Clene, Inc. Quarterly
2020-03-24 10K CLNN/Clene, Inc. Annual

Receive CLNN News And Ratings

See the #1 stock for the next 7 days that we like better than CLNN

CLNN Financial Statistics

Sales & Book Value

Annual Sales: $342K
Cash Flow: $-4M
Price / Cash Flow: 0
Annual Sales: $-1.21
Price / Book: 13.16

Profitability

EPS (TTM): -3.39240
Net Income (TTM): $-30.5M
Gross Margin: $-1.4M
Return on Equity: -4726.49%
Return on Assets: -118.52%

Clene, Inc. Earnings Forecast

Key Clene, Inc. Financial Ratios

  • The Gross Profit Margin over the past 6 years for CLNN is -401.46%.
  • The Selling, General & Administrative Expenses for CLNN have been equal to 3,890.94% of Gross Profit Margin.
  • The Research & Development expenses have been 5,461.70% of Revenue.
  • The Net Earning history of CLNN is -11,520.47% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 1 years.

Clene, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CLNN
CUSIP: 185634
Website: clene.com

Debt

Debt-to-Equity Ratio: -1.72
Current Ratio: 1.53
Quick Ratio: 0.95

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CLNN Technical Analysis vs Fundamental Analysis

Sell
15
Clene, Inc. (CLNN) is a Sell

Is Clene, Inc. a Buy or a Sell?

  • Clene, Inc. stock is rated a Sell
    The current Clene, Inc. [CLNN] share price is $5.77. The Score for CLNN is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.